SSL International plc 01 Highlights Annual Report 2003 We are committed to maximising shareholder value from our strong portfolio of healthcare products.
We shall continue to build on our skills and heritage to exploit the full potential of our global brands and business strengths.
m m 2003 2002 Turnover 623.9 592.4 Operating profit 82.0 54.1 Pre-tax profit 39.1 2.9 Basic earnings per share 13.1p 7.0 p Dividend per share 12.3p 12.3 p Net debt 292.0 307.9 Before exceptional items.
Subject to approval of final dividend by shareholders at the AGM.
Turnover Operating profit m m 623.9 82.0 A rationalisation of the Durex condom Investment in state-of-the-art New technology is behind the recent global portfolio has ensured greater manufacturing facilities continues to launch of next-generation products manufacturing productivity and maintain world-class quality standards.
in the key corn and blister category enhanced customer service.
